Magnetic nanoparticle carrier for targeted drug delivery: Perspective, outlook and design
Source abstract
Abstract
The primary challenge in the delivery of a drug to a tumour site is to target the anticancer drug specifically into and around tumours at concentrations that will decrease their growth and/or viability. Excellent vehicles to achieve targeted drug delivery are magnetic nanocarriers. A approach to accomplish this objective is to fabricate a novel temperature and pH-responsive magnetic nanocarrier that combines tumour targeting and controlled release. In addition to controlled release, these carriers simultaneously offer the possibility of imaging the delivery process by magnetic resonance imaging. The novel aspect of this approach is the combination of thermal and pH sensitivity of the drug containing shell with magnetic properties of the core in a single unit. Furthermore, application of an external magnetic field will heat the nanoparticles and thus nanoparticle containing cells. The targeted heat will aid in the killing of tumour cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. 10.1039/b507779f10.1039/b507779f ↗
2. 10.1021/jm040074b10.1021/jm040074b ↗
3. 10.1016/S0304-8853(99)00088-810.1016/S0304-8853(99)00088-8 ↗
4. 10.1016/j.copbio.2003.10.00710.1016/j.copbio.2003.10.007 ↗
5. 10.1021/la063619910.1021/la0636199 ↗
6. Rana S., Gallo A., Srivastava R. S., and Misra R. D. K.: Acta Biomater. 2007, 3, 233.10.1016/j.actbio.2006.10.006 ↗
7. Weitman S. D., Lark R. H., Coney L. R., Fort D. W., Frasca V., Zurawski V. R., and Kamen B. A.: Cancer Res. 1992, 52, 3396.
8. 10.1146/annurev.nu.16.070196.00244110.1146/annurev.nu.16.070196.002441 ↗
9. 10.1016/S0169-409X(02)00042-X10.1016/S0169-409X(02)00042-X ↗
10. 10.1074/jbc.274.16.1108610.1074/jbc.274.16.11086 ↗
11. 10.1016/j.jmmm.2005.02.04010.1016/j.jmmm.2005.02.040 ↗
12. 10.1002/anie.20050181910.1002/anie.200501819 ↗
13. 10.1021/la060371e10.1021/la060371e ↗
14. 10.1081/DDC-12000642810.1081/DDC-120006428 ↗
15. 10.1016/S0169-409X(01)00203-410.1016/S0169-409X(01)00203-4 ↗
16. 10.1295/polymj.33.10810.1295/polymj.33.108 ↗
17. Grinberg V. Y., Gronberg N. V., Usov A. I., Shusharina N. P., Khokhlov A. R., and de Kruif K. G.: Biomacromolecules, 200,1, 2, 874.
18. 10.1039/B406727D10.1039/B406727D ↗
19. 10.1016/j.ijpharm.2006.01.04510.1016/j.ijpharm.2006.01.045 ↗
20. Rana S., Rawat J., Sorensson M. M., and Misra R. D. K.: Acta Biomater. 2006, 2, 421.10.1016/j.actbio.2006.03.005 ↗
21. Rana S., Rawat J., and Misra R. D. K.: Acta Biomater. 2005, 1, 691.10.1016/j.actbio.2005.07.007 ↗
22. 10.1016/j.mseb.2005.03.01610.1016/j.mseb.2005.03.016 ↗
23. 10.1016/j.mseb.2004.04.01410.1016/j.mseb.2004.04.014 ↗
24. 10.1016/j.physb.2003.12.01710.1016/j.physb.2003.12.017 ↗
25. 10.1016/j.jmmm.2003.11.01510.1016/j.jmmm.2003.11.015 ↗
26. Zhang J. L., Rana S., Srivastava R. S., Misra R. D. K.: Acta Biomater. 2008, 4, 40.10.1016/j.actbio.2007.06.006 ↗
27. Gupta A. K. · Nanobiosc · 2005 · 4137
28. 10.1016/S0168-3659(01)00281-410.1016/S0168-3659(01)00281-4 ↗
29. 10.1016/S0169-409X(02)00229-610.1016/S0169-409X(02)00229-6 ↗
30. 10.1021/bc00024a01510.1021/bc00024a015 ↗
31. 10.1016/0168-3659(95)00160-310.1016/0168-3659(95)00160-3 ↗
32. Trail P. A., Willner D., Knipe J., Henderson A. J., Lasch S. J., Zoeckler M. E., TrailSmith M. D., Doyle T. W., King H. D., Casazza A. M., Braslawsky G. R., Brown J., Hofstead S. J., Greenfield R. S., Firestone R. A., Mosure K., Kadow K. F., Yang M. B., Hellstrom K. E., and Hellstrom I.: Cancer Res. 1997, 57, 100.
33. 10.1021/bc980100i10.1021/bc980100i ↗
34. Zhang J., and Misra R. D. K.: Acta Biomater. 2007, 3, 838.10.1016/j.actbio.2007.05.011 ↗
35. 10.1021/bm025651x10.1021/bm025651x ↗
36. 10.1016/j.ijpharm.2003.03.00210.1016/j.ijpharm.2003.03.002 ↗
37. 10.1016/S0169-409X(01)00204-610.1016/S0169-409X(01)00204-6 ↗
38. 10.1002/adma.20040036210.1002/adma.200400362 ↗
39. Needham D. · Drug Deliv. Rev · 2001
40. 10.1016/j.ejpb.2004.02.01610.1016/j.ejpb.2004.02.016 ↗